Zobrazeno 1 - 10
of 44
pro vyhledávání: '"D. Ellbrück"'
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 116:1322-1330
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 116:1307-1312
In three patients painful reddening of a well-circumscribed area of the skin occurred within five days of starting anticoagulant treatment with phenprocoumon (Marcumar), and within a short time it developed into a full-blown picture of coumarin necro
Publikováno v:
Fibrinolysis and Proteolysis. 14:343-350
In a substudy on patients undergoing thrombolytic therapy for deep venous thrombosis with different doses of recombinant tissue-type plasminogen activator (Alteplase; Actilyse®, Boehringer Ingelheim, Germany) within a multi-centre trial, several hae
Publikováno v:
Blood Coagulation and Fibrinolysis. 11:529-536
Loco-regional thrombolysis for deep-vein thrombosis (DVT) has been claimed to be equally effective and safe compared with systemic thrombolysis. It is not known whether a loco-regional thrombolytic effect exists and of what it might consist. To inves
Autor:
M. Grünewald, A. Güloglu, M.M. Müller, H. Osterhues, R. Bock, D. Ellbrück, M. Mohren, G. Schirmer, S. Ziesche, Erhard Seifried, M. Kochs
Publikováno v:
Fibrinolysis and Proteolysis. 11:137-145
Summary Reteplase, a K 2 P deletion mutant of tissue plasminogen activator, is a novel recombinant thrombolytic agent, designed primarily for bolus thrombolysis in acute myocardial infarction. To avoid early reocclusion, which had been substantial af
Publikováno v:
Transfusion Medicine and Hemotherapy. 23:244-249
Ziel: Die Studie sollte die Infektionsrate mit dem Hepatitis-C-Virus (HCV) bei 2 Patientenkollektiven untersuchen, die vor 1991 in West- und Ostdeutschland substituiert worden waren. Da unterschiedliche Herstel-lungsverfahren der Faktorpräparate (gr
Autor:
Hans-Hermann Brackmann, K. Janetzko, M. Koehler, A. Suren, H. Kuppe, K. Koerner, Erhard Seifried, Johannes Oldenburg, E. Ocklitz, R. Lissner, Harald Klüter, P. Michel, W. Schroeter, W. Weise, C. Jainta, G. Simson, Peter Hanfland, Michael Kohler, H.-J. Hertfelder, R. Lynen, N. Frickhofen, J. Riggert, R. Osmers, B. Behring, Tobias J. Legler, D. Börner, G. Schmücker, D. Ellbrück, K.-E. Klotz, J.H. Maas, I. Biester, K. Gutensohn, H. Trobisch, H. Wolf, Hartmut Gehring, Andreas Humpe
Publikováno v:
Transfusion Medicine and Hemotherapy. 23:I-VI
Publikováno v:
Annals of Hematology. 63:315-319
In this study, we report the investigation of a hemophiliac cohort, in which the last HIV-1 seroconversion occurred in 1985. We wanted to evaluate whether 5 years later the results of serological screening and polymerase chain reaction (PCR) technolo
Publikováno v:
Geburtshilfe und Frauenheilkunde. 51:655-658
We report on successful thrombolytic treatment of massive pulmonary embolism in a patient in early pregnancy with recombinant tissue-type plasminogen activator (rt-PA). Therapy was started with 20 mg rt-PA intravenously over 20 minutes, followed by t
Autor:
F Schutze, J. Limmer, Hans G. Beger, J Rist, Hermann Heimpel, D. Ellbrück, E Eisele, H Muller, Erhard Seifried
Publikováno v:
The Clinical Investigator. 72
A prospective, randomized, controlled clinical trial was performed comparing the antithrombotic efficacy of the low molecular weight heparin LMWH 21–23, (Braun) with an unfractionated heparin in elective general surgical patients over an observatio